Beyond the root: dilatation of the distal aorta in Marfan's syndrome.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMC 1861183)

Published in Heart on February 17, 2006

Authors

P M Engelfriet1, E Boersma, J G P Tijssen, B J Bouma, B J M Mulder

Author Affiliations

1: Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands.

Articles citing this

Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome. Can J Cardiol (2010) 1.40

Marfan syndrome. Part 2: treatment and management of patients. Nat Rev Cardiol (2010) 0.91

Cardiovascular magnetic resonance in Marfan syndrome. J Cardiovasc Magn Reson (2013) 0.91

Automated analysis of four-dimensional magnetic resonance images of the human aorta. Int J Cardiovasc Imaging (2010) 0.82

The distal aorta in the Marfan syndrome. Neth Heart J (2008) 0.81

Quantitative assessment of the entire thoracic aorta from magnetic resonance images. Cardiol Young (2010) 0.79

No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice. PLoS One (2014) 0.77

Natural history of Type B aortic dissection: ten tips. Ann Cardiothorac Surg (2014) 0.77

Marfan syndrome is the main independent predictor of recurrent aortic dissection in patients enrolled in the International Registry of Aortic Dissection (IRAD). J Thorac Dis (2016) 0.75

Predictors for aneurismal formation. Int J Cardiovasc Imaging (2008) 0.75

Aetiology and management of hereditary aortopathy. Nat Rev Cardiol (2017) 0.75

Longitudinal Evaluation of Aortic Hemodynamics in Marfan Syndrome: New Insights from a 4D Flow Cardiovascular Magnetic Resonance Multi-Year Follow-Up Study. J Cardiovasc Magn Reson (2017) 0.75

Altered aortic 3D hemodynamics and geometry in pediatric Marfan syndrome patients. J Cardiovasc Magn Reson (2017) 0.75

Articles cited by this

Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med (1999) 4.17

Treatment of aortic disease in patients with Marfan syndrome. Circulation (2005) 3.48

Life expectancy in the Marfan syndrome. Am J Cardiol (1995) 3.14

Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J (2004) 2.44

Management of grown up congenital heart disease. Eur Heart J (2003) 1.94

Aortic root growth in men and women with the Marfan's syndrome. Am J Cardiol (2005) 1.85

Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation (1995) 1.69

The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J (2005) 1.65

Survival and complication free survival in Marfan's syndrome: implications of current guidelines. Heart (1999) 1.62

Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann Thorac Surg (2002) 1.59

Procedures for estimating growth rates in thoracic aortic aneurysms. J Clin Epidemiol (1998) 1.39

Diameters of the thoracic aorta throughout life as measured with helical computed tomography. J Thorac Cardiovasc Surg (2002) 1.35

Localization of aortic disease is associated with intrinsic differences in aortic structure. J Surg Res (1995) 1.15

Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the Management of Adults with Congenital Heart Disease--Part II. Can J Cardiol (2001) 1.09

Normal thoracic aortic diameters by computed tomography. J Comput Assist Tomogr (1984) 1.04

Aortic dimensions in tall men and women. Am J Cardiol (1993) 1.02

Normal diameter of the thoracic aorta in adults: a magnetic resonance imaging study. Surg Radiol Anat (2003) 0.96

Magnetic resonance imaging of thoracic aortic aneurysms: comparison with other imaging methods. AJR Am J Roentgenol (1986) 0.89

Reoperations and late adverse outcome in Marfan patients following cardiovascular surgery. Eur J Cardiothorac Surg (2004) 0.89

Comparison of aortic elasticity in patients with the marfan syndrome with and without aortic root replacement. Am J Cardiol (2003) 0.86

Normal aortoiliac diameters by CT. J Comput Assist Tomogr (1988) 0.84

Evolution of healthy thoracic aortic segment diameter during follow-up of patients with aortic aneurysm or dissection: a magnetic resonance imaging study. Surg Radiol Anat (2004) 0.79

Articles by these authors

The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med (1999) 5.21

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J (2002) 4.15

Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol (2003) 3.07

Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation (2001) 3.03

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. Eur Heart J (2004) 2.67

Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart (2008) 2.40

Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation (1993) 2.32

Concern Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J (2001) 2.26

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J (2002) 2.06

Complete aortic arch obstruction: interruption or aortic coarctation? Int J Cardiovasc Imaging (2004) 1.87

Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83

Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol (1997) 1.74

Management of patients with heart failure in clinical practice: differences between men and women. Heart (2007) 1.73

Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med (2001) 1.70

Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (1996) 1.70

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial. Eur Heart J (2002) 1.63

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. Eur Heart J (2000) 1.62

Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol (1999) 1.60

Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J (2000) 1.55

Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55

Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart (2008) 1.52

Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation (1997) 1.51

Surgery in adults with congenital heart disease. Circulation (2011) 1.50

Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol (2006) 1.50

Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J (2000) 1.49

Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol (2001) 1.48

The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J (2002) 1.45

Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation (2001) 1.44

The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J (2001) 1.42

Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris. Am J Cardiol (2001) 1.42

Flow velocity and predictors of a suboptimal coronary flow velocity reserve after coronary balloon angioplasty. Eur Heart J (2002) 1.41

Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium. J Nucl Cardiol (1999) 1.40

Reprinted article "A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery". Eur J Vasc Endovasc Surg (2011) 1.40

Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease. The X-PLORER trial. Thromb Haemost (2015) 1.39

[Two patients with Eisenmenger syndrome treated with novel agents that target vasodilation of the pulmonary capillary bed]. Ned Tijdschr Geneeskd (2007) 1.38

A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart (2003) 1.35

Accurate measurement of left ventricular ejection fraction by three-dimensional echocardiography. A comparison with radionuclide angiography. Circulation (1996) 1.32

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32

Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J (2003) 1.32

Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. Am J Cardiol (2000) 1.25

Down syndrome: a cardiovascular perspective. J Intellect Disabil Res (2009) 1.21

Pulmonary artery root dilatation in Marfan syndrome: quantitative assessment of an unknown criterion. Heart (2002) 1.18

Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol (2001) 1.17

Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation (1999) 1.17

Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J (2008) 1.16

Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. Eur Heart J (2003) 1.16

Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol (1998) 1.15

Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol (1995) 1.14

Gender differences in adult congenital heart disease. Neth Heart J (2009) 1.14

Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg (2006) 1.13

Aortic valve and aortic arch pathology after coarctation repair. Heart (2003) 1.11

Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation (2003) 1.11

Relationship between tensile stress and plaque growth after balloon angioplasty treated with and without intracoronary beta-brachytherapy. Eur Heart J (2000) 1.10

Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation (1997) 1.09

Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement. Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group. Circulation (2000) 1.08

Percutaneous treatment of native aortic coarctation in adults. Neth Heart J (2011) 1.08

OPTImal CArdiac REhabilitation (OPTICARE) following Acute Coronary Syndromes: Rationale and design of a randomised, controlled trial to investigate the benefits of expanded educational and behavioural intervention programs. Neth Heart J (2013) 1.07

Per-operative stent placement in the right pulmonary artery; a hybrid technique for the management of pulmonary artery branch stenosis at the time of pulmonary valve replacement in adult Fallot patients. Neth Heart J (2011) 1.05

The apical long-axis rather than the two-chamber view should be used in combination with the four-chamber view for accurate assessment of left ventricular volumes and function. Eur Heart J (1997) 1.01

Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA (2001) 1.01

Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes. Neth Heart J (2014) 1.00

A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg (2004) 1.00

Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction. J Clin Pathol (2006) 0.99

Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med (2008) 0.99

Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol (1996) 0.99

RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results. Neth Heart J (2009) 0.99

Compound-heterozygous Marfan syndrome. Eur J Med Genet (2008) 0.98

Is cardiac CT a reproducible alternative for cardiac MR in adult patients with a systemic right ventricle? Neth Heart J (2012) 0.98

Levels and trends in cardiovascular risk factors and drug treatment in 4837 elderly Dutch myocardial infarction patients between 2002 and 2006. Neth Heart J (2012) 0.98

Current discharge management of acute coronary syndromes: data from the Rijnmond Collective Cardiology Research (CCR) study. Neth Heart J (2014) 0.96

Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996. Eur Heart J (2001) 0.96

Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J (1994) 0.96

Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque. Am J Cardiol (1999) 0.95

Advanced therapy for pulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic era. Neth Heart J (2011) 0.95

Plaque At RISK (PARISK): prospective multicenter study to improve diagnosis of high-risk carotid plaques. Int J Stroke (2013) 0.95

Validity of conjoint analysis to study clinical decision making in elderly patients with aortic stenosis. J Clin Epidemiol (2004) 0.94

Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int J Cardiol (2004) 0.94

Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators. Circulation (2000) 0.94

Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart (2007) 0.94

Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J (1999) 0.94

Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. Eur J Vasc Endovasc Surg (2004) 0.94

Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: correlations with dobutamine-atropine stress test. J Am Coll Cardiol (1994) 0.94

The Cardiology Information System: the need for data standards for integration of systems for patient care, registries and guidelines for clinical practice. Eur Heart J (2002) 0.93

Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease. Neth Heart J (2015) 0.93

Cost-effectiveness of early versus selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation. Int J Cardiol (2008) 0.93

What is new in the Marfan syndrome? Int J Cardiol (2004) 0.92

Percutaneous implantation of the CoreValve aortic valve prosthesis in patients at high risk or rejected for surgical valve replacement: Clinical evaluation and feasibility of the procedure in the first 30 patients in the AMC-UvA. Neth Heart J (2010) 0.92

ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters. Heart (2002) 0.92

Quantitative assessment of the pressure and volume overloaded right ventricle: imaging is a real challenge. Int J Cardiovasc Imaging (2002) 0.92

Bicuspid stenotic aortic valves: clinical characteristics and morphological assessment using MRI and echocardiography. Neth Heart J (2011) 0.92

Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med (1994) 0.92